Skip to main content
Skip to recall details
Verified · FDAClass II — Possible RiskMedications

Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company Clear Eyes Recall 2026

Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare companyIssued September 15, 2026Updated Reviewed by the Recall Watch editorial team

Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) , 0.5 fl oz (15mL) per dropper bottle, STERILE, Dist. by Medtech Products Inc., Tarry — recalled per FDA on 9/15/2026. Reason: Lack of Assurance of Sterility.

Agency
FDA
Issued
Sep 15, 2026
Brand
Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company
Distribution
1 states
Lots affected
20
What to do right now

Steps to take for this recall

  1. Stop using it

    Take it out of rotation. Don't consume, wear, or operate.

  2. Verify the match

    Compare lot numbers, UPCs, and dates against your product.

  3. Return or dispose

    Follow the manufacturer's instructions to refund or safely dispose.

Verified summary of the official U.S. Food and Drug Administration notice · Issued September 15, 2026 · Last synced Nov 1, 2026

What's recalled

Clear Eyes Redness Relief, Lubricant/Redness Reliever Eye Drops (glycerin 0.25%, naphazoline hydrochloride 0.012%) , 0.5 fl oz (15mL) per dropper bottle, STERILE, Dist. by Medtech Products Inc., Tarrytown, NY 10591. NDC: 67172-797-15

Available at AmazonAd
White first-aid box with bandages

Restock your medicine cabinet

First-aid kits, thermometers and OTC basics, searched on Amazon.

Shop at Amazon.com

Need it delivered? Start a free Amazon Prime trial.

Why it was recalled

Lack of Assurance of Sterility

Affected products & lot numbers
20 lots called out

Affected Lot Numbers

Check your product label — do not use if your lot number appears below.

Lot Number
Lot #: RL25G02
RL25G03
RL25G04
Exp. Date Jul-27
RL25H02
RL25H03
RL25H04
Exp. Date Aug-27
RL25K01
RL25K02
RL25K03
RL25K04
Exp. Date Sep-27
RL25M01
RL25M02
RL25M03
RL25M04
Exp. Date Oct-27
RL25N01
RL25N02
Where was it sold
1 state

Nationwide in the USA.

nationwide
Official noticefda.gov
More recalls like this
6 related — by brand, contaminant, and category

Frequently asked questions

Is the Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company recall still active?

Yes, this recall is currently active as of September 15, 2026. Do not use or consume the affected product.

What lot numbers are affected?

Affected lot numbers: Lot #: RL25G02, RL25G03, RL25G04, Exp. Date Jul-27, RL25H02, RL25H03, RL25H04, Exp. Date Aug-27, RL25K01, RL25K02, RL25K03, RL25K04, Exp. Date Sep-27, RL25M01, RL25M02, RL25M03, RL25M04, Exp. Date Oct-27, RL25N01, RL25N02. Check the label on your product.

What should I do if I have the recalled Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company?

Do not consume or use this product. Return it to the store for a full refund, or dispose of it safely.